PHARMA MAR, S.A. «12345...» Page 3 out of 18 from 01/07/1988 to 29/04/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 12/06/2019 17:45 PHARMA MAR, S.A. Employees share and stock ownership schemes The Executive Committee of Pharma Mar, S.A. has decided to implement the Free of Charge Stock Ownership Plan approved by resolution of the Annual General Shareholders´ Meeting of 28 June 2018. Register number: 279065 03/06/2019 09:31 PHARMA MAR, S.A. Announcements of public presentations and meetings Conference call related to the Zepsyre results recently presented at ASCO by Dr. Paz Ares. Register number: 278779 Related with 278775 of 01/06/2019 (22:48) 01/06/2019 22:48 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Information about the results presented at the annual meeting of the American Society of Clinical Oncology (ASCO) concerning Zepsyre Register number: 278775 Related with 278282 of 16/05/2019 (07:37) 23/05/2019 15:16 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings. - Composition of the board of directors The Company announces decision of the Board of Directors to call the Ordinary General Shareholders´ Meeting on 25/06/2019 and 26/06/2019, respectively, on the first and second call notice. The Company sends notice of call and proposed resolutions Register number: 278507 23/05/2019 14:49 PHARMA MAR, S.A. Transmissions and purchases of capital undertakings The Board of Directors of Pharma Mar has approved the signing of a contract for the sale of the shares of its subsidiary Zelnova Zeltia, subject to the approval of the General Shareholders Meeting. Register number: 278505 Related with 274204 of 28/01/2019 (19:45) 16/05/2019 07:37 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Abstract information to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) concerning Lurbinectedin Register number: 278282 Related with 276625 of 01/04/2019 (08:18) 15/05/2019 07:36 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks American Society of Clinical Oncology (ASCO) selects a lurbinectedin abstract for “Best of ASCO” program. Register number: 278266 26/04/2019 18:37 PHARMA MAR, S.A. Credit ratings Axesor ratifies the rating of Pharma Mar, S.A. and its outlook as stable. Register number: 277498 26/04/2019 18:30 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding the Q1 2019 results Register number: 277497 26/04/2019 18:19 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del primer trimestre de 2019 Register number: 277496 Page 3 out of 18 «12345...»